The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by University of Roma La Sapienza.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Roma La Sapienza
ClinicalTrials.gov Identifier:
NCT00470769
First received: May 7, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

It is generally assumed that renal blood flow is symmetric in the absence of renal artery stenosis. The importance of studying the function of both kidneys separately is because it cannot be assumed that they are functionally equal.The aim of the present study is to evaluate whether this is really in patients with essential hypertension and/or moderate kidneys loss.


Condition Intervention
Hypertension
Renal Failure
Procedure: Color-Doppler Ultrasound, 99mTc-DTPA scintigraphy

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: Color-Doppler Ultrasonography vs 99mTc-DTPA Scintigraphy to Assess the Renal Blood Flow

Resource links provided by NLM:


Further study details as provided by University of Roma La Sapienza:

Estimated Enrollment: 2006
Study Start Date: September 2006
Estimated Study Completion Date: May 2007
Detailed Description:

To validate color Doppler ultrasonography of renal arteries for the assessment of renal blood flow (RBF), we comparing left and right RBF estimates and their sum (total RBF) by echo-Doppler with data obtained by 99mTc-DTPA scintigraphy in 50 patients with hypertension and/or moderate renal failure, compared with 30 normal control subjects.

  Eligibility

Ages Eligible for Study:   30 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients with hypertension
  • Patients with moderate renal insufficiency
  • Normal subjects

Exclusion Criteria:

  • Patients with solitary kidney function
  • Patients with renal artery stenosis
  • Patients underwent renal angioplasty and stenting
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00470769

Contacts
Contact: Rosario Cianci, MD +39335206441 ciancirosario@tin.it

Locations
Italy
Giorgio Fuiano Recruiting
Catanzaro, Italy, 88020
University of Rome La Sapienza Recruiting
Roma, Italy, 00100
Contact: Rosario Cianci, MD    +39335206441    ciancirosario@tin.it   
Contact: Giorgio Fuiano, MD    +39 0961775360    gfuiano@libero.it   
Rosario Cianci Recruiting
Rome, Italy, 00100
Sponsors and Collaborators
University of Roma La Sapienza
Investigators
Principal Investigator: Rosario Cianci, MD Department Of Clinic Medicine, Chair of Nephrology
Study Director: Giorgio Fuiano, MD University of Catanzaro
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00470769     History of Changes
Other Study ID Numbers: CR-UR-00001
Study First Received: May 7, 2007
Last Updated: May 7, 2007
Health Authority: Italy: National Bioethics Committee

Keywords provided by University of Roma La Sapienza:
Color-Doppler Ultrasonography
Renal scintigraphy
Kidney failure
GFR

Additional relevant MeSH terms:
Hypertension
Renal Insufficiency
Cardiovascular Diseases
Kidney Diseases
Urologic Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on October 29, 2014